Drug
KXV01 TCR Lentinvivo Injection
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Not yet recruiting4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
not_yet_recruiting4100%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_1
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
NCT07307053
not_yet_recruitingphase_1
Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
NCT07275853
not_yet_recruitingphase_1
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
NCT07207681
not_yet_recruitingphase_1
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
NCT07196579
Clinical Trials (4)
Showing 4 of 4 trials
NCT07307053Phase 1
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
NCT07275853Phase 1
Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
NCT07207681Phase 1
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
NCT07196579Phase 1
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4